NCT01576861View on ClinicalTrials.gov

Long-Term Efficacy and Safety of Growth Hormone Replacement Therapy in Chronic Heart Failure

PHASE2CompletedINTERVENTIONAL
Enrollment

28

Participants

Timeline

Start Date

January 31, 2007

Primary Completion Date

March 31, 2011

Study Completion Date

December 31, 2011

Conditions
Growth Hormone DeficiencyChronic Heart Failure
Interventions
DRUG

Somatotropin

Subcutaneous Somatotropin (recombinant Human Growth Hormone) 0,012 mg/kg every second day

Trial Locations (1)

80131

Department of Internal Medicine, Cardiovascular and Immunological Sciences, Napoli

All Listed Sponsors
lead

Federico II University

OTHER

NCT01576861 - Long-Term Efficacy and Safety of Growth Hormone Replacement Therapy in Chronic Heart Failure | Biotech Hunter | Biotech Hunter